Global Immuno-oncology Assay Market By Region
Data Source: Wantstats Repository
Growth Outlook
- The oncology Assay Market By Indication portion of the Global Immuno market is on a steady long-term growth path. Segment value stands at roughly USD 216 Million in 2026 and is projected to reach USD 453 Million by 2035 — a gain of about 109% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Lung Cancer leads, holding roughly 26% of segment value — the single largest regional share. Breast Cancer is the second-largest contributor. Melanoma, Others, Colorectal Cancer and Ovarian Cancer make up the remainder, in descending order.
- By 2035, Lung Cancer alone is expected to reach USD 129 Million, with Melanoma at USD 90 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowPowering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Global Immuno-oncology Assay Market By Indication
One-time
$49



